Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern
Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment,...
Saved in:
Published in | Journal of gastroenterology Vol. 58; no. 12; pp. 1237 - 1251 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Nature Singapore
01.12.2023
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).
Methods
We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.
Results
Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8
+
PD1
+
T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8
+
PD1
+
T cells (odds ratio, 0.01; 95% CI 0.00–38.9,
p
= 0.004) was an independent risk factor in NASH and significantly decreased in AIH.
Conclusions
The decreased frequency of peripheral CD8
+
PD1
+
T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. |
---|---|
AbstractList | Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).
We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.
Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8
PD1
T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8
PD1
T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.
The decreased frequency of peripheral CD8
PD1
T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8.sup.+ PD1.sup.+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8.sup.+ PD1.sup.+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. The decreased frequency of peripheral CD8.sup.+ PD1.sup.+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). Methods We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Results Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8.sup.+ PD1.sup.+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8.sup.+ PD1.sup.+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. Conclusions The decreased frequency of peripheral CD8.sup.+ PD1.sup.+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).BACKGROUNDNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.METHODSWe assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.RESULTSSeveral significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.The decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.CONCLUSIONSThe decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. BackgroundNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).MethodsWe assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.ResultsSeveral significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00–38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.ConclusionsThe decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). Methods We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Results Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 + PD1 + T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 + PD1 + T cells (odds ratio, 0.01; 95% CI 0.00–38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. Conclusions The decreased frequency of peripheral CD8 + PD1 + T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity. |
Audience | Academic |
Author | Ikeuchi, Kazuhiko Tsutsumi, Takeya Fujishiro, Mitsuhiro Yotsuyanagi, Hiroshi Koike, Kazuhiko Kado, Akira Moriya, Kyoji Okushin, Kazuya |
Author_xml | – sequence: 1 givenname: Akira surname: Kado fullname: Kado, Akira organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Division for Health Service Promotion, The University of Tokyo – sequence: 2 givenname: Takeya orcidid: 0000-0003-0851-1887 surname: Tsutsumi fullname: Tsutsumi, Takeya email: takeyatsutsumi@g.ecc.u-tokyo.ac.jp organization: Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo – sequence: 3 givenname: Hiroshi surname: Yotsuyanagi fullname: Yotsuyanagi, Hiroshi organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo – sequence: 4 givenname: Kazuhiko surname: Ikeuchi fullname: Ikeuchi, Kazuhiko organization: Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo – sequence: 5 givenname: Kazuya surname: Okushin fullname: Okushin, Kazuya organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo – sequence: 6 givenname: Kyoji surname: Moriya fullname: Moriya, Kyoji organization: Division for Health Service Promotion, The University of Tokyo – sequence: 7 givenname: Kazuhiko surname: Koike fullname: Koike, Kazuhiko organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Department of Gastroenterology, Kanto Central Hospital – sequence: 8 givenname: Mitsuhiro surname: Fujishiro fullname: Fujishiro, Mitsuhiro organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37707595$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks9u3CAQxlGVqtmkfYEeKqReenEKBox9jKL0jxS1l_aMWDzeJbXBBbzSPkjft7PdRGmjKkKANPy-D5iZM3ISYgBCXnN2wRnT7zNjSqiK1QInE221f0ZWXGJIdXV9Qlask7LiXMtTcpbzLWNcMNW-IKdCa6ZVp1bk15cYfNjZ7HdA7TynaN2Wlkh96L2zBWjy-QcdrCsxZRoHio-wo4vbOHpHcwFb4hZmW3zxeL6DNKKNDxtqlxL9NC0B6AOwthl6GgOdIfl5C8mOdNxP8za6PV6GWIEUXpLngx0zvLrbz8n3D9ffrj5VN18_fr66vKmc0k2pmsGKttOuHiyvbasFt7yXjEne8962ci3WAjo1NFxIxxzTaycbrYBLXIa-Fefk3dEX__1zgVzM5LODcbQB4pJN3Tay7RrFa0TfPkJv45IwFQeq46qtFfuL2tgRjA9DLMm6g6m51FoozmrdIXXxHwpHD5N3WOTBY_wfwZu7y5f1BL2Zk59s2pv7OiLQHgGXYs4JBuN8wZTHgM5-NJyZQ8uYY8sYfKn50zJmj9L6kfTe_UmROIoywmED6SEbT6h-A06u1gc |
CitedBy_id | crossref_primary_10_1038_s41598_024_76084_8 crossref_primary_10_1007_s42452_024_06124_5 crossref_primary_10_1016_j_ijbiomac_2024_135256 |
Cites_doi | 10.1155/2013/607073 10.1016/S0168-8278(99)80297-9 10.1002/hep.21541 10.1111/j.1572-0241.2004.30444.x 10.1111/hepr.12210 10.1007/s00535-015-1129-1 10.1016/j.ebiom.2021.103768 10.1016/S0016-5085(99)70506-8 10.1371/journal.pone.0239481 10.1016/j.jsbmb.2015.07.020 10.1111/j.1872-034X.2007.00150.x 10.2169/internalmedicine.8887-17 10.1016/j.jhep.2015.06.030 10.3389/fimmu.2020.575572 10.1016/j.cyto.2014.09.011 10.1515/cclm-2013-0926 10.1038/nrgastro.2013.41 10.14309/ajg.0000000000000676 10.1002/cyto.a.24272 10.3389/fimmu.2019.01255 10.1089/vim.2018.0035 10.1002/hep.28776 10.1002/hep.25762 10.1055/s-0040-1713006 10.1073/pnas.1608873113 10.1159/000440747 10.1038/s41575-019-0210-2 10.4049/jimmunol.1501175 10.14715/cmb/2018.64.5.19 10.1016/j.jhep.2017.09.021 10.1038/s41467-021-24734-0 10.1016/j.immuni.2012.06.016 10.1371/journal.pone.0143380 10.1007/s00535-019-01565-x 10.3389/fphar.2019.00244 10.1007/s12016-013-8383-x 10.1002/cyto.10092 10.1016/j.ejim.2020.02.001 10.1007/s00535-022-01932-1 10.1038/nature14468 10.1016/j.jhep.2020.05.053 10.1038/nrc3239 10.1111/hepr.13683 10.1177/0961203315604910 10.1038/nrgastro.2015.200 10.1080/00365521.2016.1233576 10.1016/j.jhep.2019.08.024 10.1007/s00535-020-01679-7 10.1111/hepr.13764 10.1146/annurev-med-012017-043208 10.1053/j.gastro.2008.06.042 10.3389/fimmu.2019.02172 10.4049/jimmunol.1900124 10.1016/j.cellimm.2017.12.008 10.1038/s41577-021-00639-3 10.1002/cpt.2423 10.1007/s00535-021-01796-x 10.3389/fimmu.2019.01065 10.1073/pnas.97.3.1184 10.1002/hep.23599 10.3389/fimmu.2019.00082 10.1016/j.jhep.2012.02.029 10.1001/jamanetworkopen.2019.12565 10.1097/MCG.0000000000001817 10.1007/s00535-016-1267-0 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 Springer The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 Springer – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH H94 K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s00535-023-02038-y |
DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1435-5922 |
EndPage | 1251 |
ExternalDocumentID | A773510279 37707595 10_1007_s00535_023_02038_y |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Miyakawa Memorial Research Foundation funderid: http://dx.doi.org/10.13039/501100007669 – fundername: The University of Tokyo – fundername: Japan Agency for Medical Research and Development grantid: JP22fk0210090 funderid: http://dx.doi.org/10.13039/100009619 – fundername: Japan Agency for Medical Research and Development grantid: JP22fk0210090 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BKNYI BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ INH IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH LAS LLZTM M0R M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PCD PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7M YLTOR Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY AEIIB PMFND 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS PUEGO 7X8 |
ID | FETCH-LOGICAL-c576t-6fa3897c2fa12a8731a1d40041d1da84b3b3e95f6134c0c07bc4675e1475efd83 |
IEDL.DBID | U2A |
ISSN | 0944-1174 1435-5922 |
IngestDate | Tue Aug 05 10:31:52 EDT 2025 Sat Aug 23 14:30:24 EDT 2025 Tue Jun 17 22:03:09 EDT 2025 Tue Jun 10 21:06:42 EDT 2025 Mon Jul 21 06:04:53 EDT 2025 Tue Jul 01 04:34:20 EDT 2025 Thu Apr 24 22:54:58 EDT 2025 Fri Feb 21 02:43:59 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Peripheral blood mononuclear cells Flow cytometry Peripheral lymphocyte frequency Nonalcoholic steatohepatitis Autoimmune hepatitis |
Language | English |
License | 2023. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c576t-6fa3897c2fa12a8731a1d40041d1da84b3b3e95f6134c0c07bc4675e1475efd83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0851-1887 |
OpenAccessLink | https://link.springer.com/10.1007/s00535-023-02038-y |
PMID | 37707595 |
PQID | 2891582502 |
PQPubID | 33411 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_2864896512 proquest_journals_2891582502 gale_infotracmisc_A773510279 gale_infotracacademiconefile_A773510279 pubmed_primary_37707595 crossref_citationtrail_10_1007_s00535_023_02038_y crossref_primary_10_1007_s00535_023_02038_y springer_journals_10_1007_s00535_023_02038_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore – name: Japan – name: Tokyo |
PublicationTitle | Journal of gastroenterology |
PublicationTitleAbbrev | J Gastroenterol |
PublicationTitleAlternate | J Gastroenterol |
PublicationYear | 2023 |
Publisher | Springer Nature Singapore Springer Springer Nature B.V |
Publisher_xml | – name: Springer Nature Singapore – name: Springer – name: Springer Nature B.V |
References | Younes, Govaere, Petta (CR11) 2020; 115 Tokushige, Hyogo, Nakajima (CR2) 2016; 51 Chalasani, Younossi, Lavine (CR8) 2012; 55 Raphael, Nalawade, Eagar (CR37) 2015; 74 Ugarte-Gil, Sánchez-Zúñiga, Gamboa-Cárdenas (CR16) 2016; 25 Van Herck, Weyler, Kwanten (CR57) 2019; 10 Shen, Xu, Yu (CR45) 2018; 31 Penna, Pilli, Zerbini (CR46) 2007; 45 Abe, Fujita, Hayashi (CR24) 2020; 15 Kado, Tsutsumi, Enooku (CR12) 2019; 54 Dalekos, Gatselis, Zachou (CR65) 2020; 75 Hu, Zhao, Wang (CR27) 2014; 52 Matteoni, Younossi, Gramlich (CR28) 1999; 116 Huby, Gautier (CR10) 2022; 22 Stiglund, Strand, Cornillet (CR42) 2019; 10 Suarez-Fueyo, Tsokos, Kwok (CR54) 2019; 10 Seike, Mizukoshi, Yamada (CR17) 2020; 55 Abe, Hiasa, Onji (CR58) 2013; 2013 McKinney, Lee, Jayne (CR49) 2015; 523 Anstee, Targher, Day (CR1) 2013; 10 Cueto-Sanchez, Niu, Del Campo-Herrera (CR20) 2021; 110 (CR25) 2015; 63 Huang, Wang, He (CR36) 2018; 64 Woods, Hazlehurst, Tomlinson (CR6) 2015; 154 Vonghia, Magrone, Verrijken (CR22) 2015; 10 Koda, Teratani, Chu (CR51) 2021; 12 Tanaka, Notohara (CR32) 2021; 51 Komura, Ohta, Seike (CR7) 2018; 57 Tiniakos, Brain, Bury (CR31) 2015; 33 Wang, Luo, Wan (CR44) 2020; 72 Boes, Schmidt, Linkemann (CR52) 2000; 97 Renand, Cervera-Marzal, Gil (CR19) 2020; 73 Hashimoto, Kamphorst, Im (CR43) 2018; 69 Zhang, Chikuma, Hori (CR40) 2016; 113 Sebode, Wigger, Filpe (CR63) 2019; 10 Xiao, Ai, Yan (CR60) 2018; 327 Lin, Fan (CR18) 2022; 75 Lynch, Nowak, Varghese (CR61) 2012; 37 Sutti, Albano (CR9) 2020; 17 Peiseler, Sebode, Franke (CR21) 2012; 57 Yoshioka, Taniai, Hashimoto (CR53) 2014; 44 Tamaki, Kurosaki, Huang (CR14) 2022; 52 Bergeron, Nicholson, Phaneuf (CR35) 2002; 50 Kamada, Nakamura, Isobe (CR15) 2023; 58 Aarslev, Dige, Greisen (CR48) 2017; 52 Niwa, Sasaki, Haratake (CR4) 2007; 37 Alvarez, Berg, Bianchi (CR30) 1999; 31 CR29 Wang, Zhong, Zhang (CR38) 2021; 99 Bovensiepen, Schakat, Sebode (CR64) 2019; 203 Lonardo, Nascimbeni, Mantovani (CR3) 2018; 68 Tokushige, Ikejima, Ono (CR50) 2021; 56 Tsuneyama, Baba, Kikuchi (CR33) 2013; 45 CR26 Adams, Chan (CR55) 2020; 40 Syn, Oo, Pereira (CR62) 2010; 51 CR23 Kido, Watanabe, Okazaki (CR47) 2008; 135 Adams, Lindor, Angulo (CR5) 2004; 99 Pardoll (CR41) 2012; 12 Ajmera, Perito, Bass (CR13) 2017; 65 Heymann, Tacke (CR59) 2016; 13 Hansel, Erschfeld, Baues (CR34) 2019; 10 Wang, Feng, Yan (CR39) 2020; 11 Rau, Schilling, Meertens (CR56) 2016; 196 B Zhang (2038_CR40) 2016; 113 T Komura (2038_CR7) 2018; 57 Y Kamada (2038_CR15) 2023; 58 M Abe (2038_CR58) 2013; 2013 A Kado (2038_CR12) 2019; 54 A Tanaka (2038_CR32) 2021; 51 H Niwa (2038_CR4) 2007; 37 K Aarslev (2038_CR48) 2017; 52 CA Matteoni (2038_CR28) 1999; 116 WK Syn (2038_CR62) 2010; 51 F Heymann (2038_CR59) 2016; 13 MF Ugarte-Gil (2038_CR16) 2016; 25 K Tsuneyama (2038_CR33) 2013; 45 T Huby (2038_CR10) 2022; 22 H Wang (2038_CR39) 2020; 11 K Abe (2038_CR24) 2020; 15 M Rau (2038_CR56) 2016; 196 M Peiseler (2038_CR21) 2012; 57 H Wang (2038_CR44) 2020; 72 F Xiao (2038_CR60) 2018; 327 LA Adams (2038_CR55) 2020; 40 S Sutti (2038_CR9) 2020; 17 M Bergeron (2038_CR35) 2002; 50 DM Pardoll (2038_CR41) 2012; 12 QM Anstee (2038_CR1) 2013; 10 T Seike (2038_CR17) 2020; 55 L Vonghia (2038_CR22) 2015; 10 XH Shen (2038_CR45) 2018; 31 LA Adams (2038_CR5) 2004; 99 K Tokushige (2038_CR50) 2021; 56 C Hansel (2038_CR34) 2019; 10 GN Dalekos (2038_CR65) 2020; 75 European Association for the Study of the Liver (2038_CR25) 2015; 63 F Alvarez (2038_CR30) 1999; 31 SZ Lin (2038_CR18) 2022; 75 S Hu (2038_CR27) 2014; 52 2038_CR29 Y Yoshioka (2038_CR53) 2014; 44 2038_CR23 2038_CR26 N Tamaki (2038_CR14) 2022; 52 M Boes (2038_CR52) 2000; 97 A Penna (2038_CR46) 2007; 45 CS Bovensiepen (2038_CR64) 2019; 203 A Lonardo (2038_CR3) 2018; 68 CP Woods (2038_CR6) 2015; 154 M Sebode (2038_CR63) 2019; 10 SR Wang (2038_CR38) 2021; 99 M Hashimoto (2038_CR43) 2018; 69 DG Tiniakos (2038_CR31) 2015; 33 EF McKinney (2038_CR49) 2015; 523 Y Koda (2038_CR51) 2021; 12 N Chalasani (2038_CR8) 2012; 55 M Kido (2038_CR47) 2008; 135 V Ajmera (2038_CR13) 2017; 65 MA Van Herck (2038_CR57) 2019; 10 N Stiglund (2038_CR42) 2019; 10 A Suarez-Fueyo (2038_CR54) 2019; 10 L Lynch (2038_CR61) 2012; 37 LQ Huang (2038_CR36) 2018; 64 A Renand (2038_CR19) 2020; 73 R Younes (2038_CR11) 2020; 115 A Cueto-Sanchez (2038_CR20) 2021; 110 I Raphael (2038_CR37) 2015; 74 K Tokushige (2038_CR2) 2016; 51 |
References_xml | – volume: 2013 year: 2013 ident: CR58 article-title: T helper 17 cells in autoimmune liver diseases publication-title: Clin Dev Immunol doi: 10.1155/2013/607073 – volume: 31 start-page: 929 year: 1999 end-page: 938 ident: CR30 article-title: International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80297-9 – volume: 45 start-page: 588 year: 2007 end-page: 601 ident: CR46 article-title: Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection publication-title: Hepatology doi: 10.1002/hep.21541 – volume: 99 start-page: 1316 year: 2004 end-page: 1320 ident: CR5 article-title: The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2004.30444.x – volume: 44 start-page: 947 year: 2014 end-page: 955 ident: CR53 article-title: Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy publication-title: Hepatol Res doi: 10.1111/hepr.12210 – volume: 51 start-page: 586 year: 2016 end-page: 596 ident: CR2 article-title: Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey publication-title: J Gastroenterol doi: 10.1007/s00535-015-1129-1 – volume: 75 year: 2022 ident: CR18 article-title: Peripheral immune cells in NAFLD patients: a spyhole to disease progression publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103768 – volume: 116 start-page: 1413 year: 1999 end-page: 1419 ident: CR28 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 15 year: 2020 ident: CR24 article-title: Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis publication-title: PLoS ONE doi: 10.1371/journal.pone.0239481 – volume: 154 start-page: 94 year: 2015 end-page: 103 ident: CR6 article-title: Glucocorticoids and non-alcoholic fatty liver disease publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2015.07.020 – volume: 37 start-page: 923 year: 2007 end-page: 931 ident: CR4 article-title: Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2007.00150.x – ident: CR29 – volume: 57 start-page: 807 year: 2018 end-page: 812 ident: CR7 article-title: The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis publication-title: Intern Med doi: 10.2169/internalmedicine.8887-17 – volume: 63 start-page: 971 year: 2015 end-page: 1004 ident: CR25 article-title: EASL clinical practice guidelines: autoimmune hepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2015.06.030 – volume: 11 year: 2020 ident: CR39 article-title: Regulatory T cells in autoimmune hepatitis: Unveiling their roles in mouse models and patients publication-title: Front Immunol doi: 10.3389/fimmu.2020.575572 – volume: 74 start-page: 5 year: 2015 end-page: 17 ident: CR37 article-title: T cell subsets and their signature cytokines in autoimmune and inflammatory diseases publication-title: Cytokine doi: 10.1016/j.cyto.2014.09.011 – volume: 52 start-page: 1533 year: 2014 end-page: 1542 ident: CR27 article-title: The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: A meta-analysis publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2013-0926 – volume: 10 start-page: 330 year: 2013 end-page: 344 ident: CR1 article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease, or cirrhosis publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.41 – volume: 115 start-page: 1289 year: 2020 end-page: 1292 ident: CR11 article-title: Presence of serum antinuclear antibodies does not impact long-term outcomes in nonalcoholic fatty liver disease publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000676 – volume: 99 start-page: 273 year: 2021 end-page: 277 ident: CR38 article-title: OMIP 071: A 31-parameter flow cytometry panel for in-depth immunophenotyping of human T-cell subsets using surface markers publication-title: Cytometry A doi: 10.1002/cyto.a.24272 – volume: 10 start-page: 1255 year: 2019 ident: CR42 article-title: Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease publication-title: Front Immunol doi: 10.3389/fimmu.2019.01255 – volume: 31 start-page: 548 year: 2018 end-page: 558 ident: CR45 article-title: Discrepant clinical significance of CD28+CD8- and CD4+CD25high regulatory T cells during the progression of hepatitis B virus infection publication-title: Viral Immunol doi: 10.1089/vim.2018.0035 – volume: 65 start-page: 65 year: 2017 end-page: 77 ident: CR13 article-title: NASH clinical research network. novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.28776 – volume: 55 start-page: 2005 year: 2012 end-page: 2023 ident: CR8 article-title: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association publication-title: Hepatology doi: 10.1002/hep.25762 – volume: 40 start-page: 331 year: 2020 end-page: 338 ident: CR55 article-title: Noninvasive tests in the assessment of NASH and NAFLD Fibrosis: Now and into the future publication-title: Semin Liver Dis doi: 10.1055/s-0040-1713006 – volume: 113 start-page: 8490 year: 2016 end-page: 8495 ident: CR40 article-title: Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1608873113 – volume: 33 start-page: 53 year: 2015 end-page: 64 ident: CR31 article-title: Role of histopathology in autoimmune hepatitis publication-title: Dig Dis doi: 10.1159/000440747 – volume: 17 start-page: 81 year: 2020 end-page: 92 ident: CR9 article-title: Adaptive immunity: an emerging player in the progression of NAFLD publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0210-2 – volume: 196 start-page: 97 year: 2016 end-page: 105 ident: CR56 article-title: Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver publication-title: J Immunol doi: 10.4049/jimmunol.1501175 – ident: CR26 – volume: 64 start-page: 113 issue: 5 year: 2018 end-page: 117 ident: CR36 article-title: Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients publication-title: Cell Mol Biol doi: 10.14715/cmb/2018.64.5.19 – volume: 68 start-page: 335 year: 2018 end-page: 352 ident: CR3 article-title: Hypertension, diabetes, atherosclerosis, and NASH: Cause or consequence? publication-title: J Hepatol doi: 10.1016/j.jhep.2017.09.021 – volume: 12 start-page: 4474 year: 2021 ident: CR51 article-title: CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells publication-title: Nat Commun doi: 10.1038/s41467-021-24734-0 – volume: 37 start-page: 574 year: 2012 end-page: 587 ident: CR61 article-title: Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production publication-title: Immunity doi: 10.1016/j.immuni.2012.06.016 – volume: 10 year: 2015 ident: CR22 article-title: Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic features publication-title: PLoS ONE doi: 10.1371/journal.pone.0143380 – volume: 54 start-page: 730 year: 2019 end-page: 741 ident: CR12 article-title: Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells publication-title: J Gastroenterol doi: 10.1007/s00535-019-01565-x – volume: 10 start-page: 244 year: 2019 ident: CR34 article-title: The inhibitory cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00244 – volume: 45 start-page: 143 year: 2013 end-page: 148 ident: CR33 article-title: Autoimmune features in metabolic liver disease: a single-center experience and review of the literature publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-013-8383-x – volume: 50 start-page: 53 year: 2002 end-page: 61 ident: CR35 article-title: Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens publication-title: Cytometry doi: 10.1002/cyto.10092 – volume: 75 start-page: 1 year: 2020 end-page: 9 ident: CR65 article-title: NAFLD and autoimmune hepatitis: do not judge a book by its cover publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2020.02.001 – volume: 58 start-page: 79 year: 2023 end-page: 97 ident: CR15 article-title: JANIT forum SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT forum publication-title: J Gastroenterol doi: 10.1007/s00535-022-01932-1 – volume: 523 start-page: 612 year: 2015 end-page: 616 ident: CR49 article-title: T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection publication-title: Nature doi: 10.1038/nature14468 – volume: 73 start-page: 1379 year: 2020 end-page: 1390 ident: CR19 article-title: Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2020.05.053 – volume: 12 start-page: 252 year: 2012 end-page: 264 ident: CR41 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat Rev Cancer doi: 10.1038/nrc3239 – volume: 51 start-page: 850 year: 2021 end-page: 859 ident: CR32 article-title: Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: a histopathological and clinical perspective publication-title: Hepatol Res doi: 10.1111/hepr.13683 – volume: 25 start-page: 233 year: 2016 end-page: 240 ident: CR16 article-title: Circulating CD4 CD28null and extra-thymic CD4 CD8 double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients publication-title: Lupus doi: 10.1177/0961203315604910 – volume: 13 start-page: 88 year: 2016 end-page: 110 ident: CR59 article-title: Immunology in the liver—from homeostasis to disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2015.200 – ident: CR23 – volume: 52 start-page: 93 year: 2017 end-page: 99 ident: CR48 article-title: Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis publication-title: Scand J Gastroenterol doi: 10.1080/00365521.2016.1233576 – volume: 72 start-page: 45 year: 2020 end-page: 56 ident: CR44 article-title: TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection publication-title: J Hepatol doi: 10.1016/j.jhep.2019.08.024 – volume: 55 start-page: 701 year: 2020 end-page: 711 ident: CR17 article-title: Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients publication-title: J Gastroenterol doi: 10.1007/s00535-020-01679-7 – volume: 52 start-page: 497 year: 2022 end-page: 507 ident: CR14 article-title: Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease publication-title: Hepatol Res doi: 10.1111/hepr.13764 – volume: 69 start-page: 301 year: 2018 end-page: 318 ident: CR43 article-title: CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions publication-title: Annu Rev Med doi: 10.1146/annurev-med-012017-043208 – volume: 135 start-page: 1333 year: 2008 end-page: 1343 ident: CR47 article-title: Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.06.042 – volume: 10 start-page: 2172 year: 2019 ident: CR54 article-title: Hyaluronic acid synthesis contributes to tissue damage in systemic lupus erythematosus publication-title: Front Immunol doi: 10.3389/fimmu.2019.02172 – volume: 203 start-page: 3148 year: 2019 end-page: 3156 ident: CR64 article-title: TNF-Producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis publication-title: J Immunol doi: 10.4049/jimmunol.1900124 – volume: 327 start-page: 13 year: 2018 end-page: 20 ident: CR60 article-title: Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression publication-title: Cell Immunol doi: 10.1016/j.cellimm.2017.12.008 – volume: 22 start-page: 429 year: 2022 end-page: 443 ident: CR10 article-title: Immune cell-mediated features of non-alcoholic steatohepatitis publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00639-3 – volume: 110 start-page: 1604 year: 2021 end-page: 1612 ident: CR20 article-title: Lymphocyte profile and immune checkpoint expression in drug-induced liver injury: An immunophenotyping study publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.2423 – volume: 56 start-page: 951 year: 2021 end-page: 963 ident: CR50 article-title: Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 publication-title: J Gastroenterol doi: 10.1007/s00535-021-01796-x – volume: 10 start-page: 1065 year: 2019 ident: CR63 article-title: Inflammatory phenotype of intrahepatic sulfatide-reactive type II NKT cells in humans with autoimmune hepatitis publication-title: Front Immunol doi: 10.3389/fimmu.2019.01065 – volume: 97 start-page: 1184 year: 2000 end-page: 1189 ident: CR52 article-title: Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.97.3.1184 – volume: 51 start-page: 1998 year: 2010 end-page: 2007 ident: CR62 article-title: Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.23599 – volume: 10 start-page: 82 year: 2019 ident: CR57 article-title: The differential roles of T cells in non-alcoholic fatty liver disease and obesity publication-title: Front Immunol doi: 10.3389/fimmu.2019.00082 – volume: 57 start-page: 125 year: 2012 end-page: 132 ident: CR21 article-title: FOXP3 regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency publication-title: J Hepatol doi: 10.1016/j.jhep.2012.02.029 – volume: 55 start-page: 2005 year: 2012 ident: 2038_CR8 publication-title: Hepatology doi: 10.1002/hep.25762 – volume: 73 start-page: 1379 year: 2020 ident: 2038_CR19 publication-title: J Hepatol doi: 10.1016/j.jhep.2020.05.053 – volume: 22 start-page: 429 year: 2022 ident: 2038_CR10 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00639-3 – volume: 31 start-page: 929 year: 1999 ident: 2038_CR30 publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80297-9 – volume: 37 start-page: 574 year: 2012 ident: 2038_CR61 publication-title: Immunity doi: 10.1016/j.immuni.2012.06.016 – volume: 55 start-page: 701 year: 2020 ident: 2038_CR17 publication-title: J Gastroenterol doi: 10.1007/s00535-020-01679-7 – volume: 10 start-page: 1065 year: 2019 ident: 2038_CR63 publication-title: Front Immunol doi: 10.3389/fimmu.2019.01065 – volume: 12 start-page: 252 year: 2012 ident: 2038_CR41 publication-title: Nat Rev Cancer doi: 10.1038/nrc3239 – volume: 50 start-page: 53 year: 2002 ident: 2038_CR35 publication-title: Cytometry doi: 10.1002/cyto.10092 – volume: 99 start-page: 1316 year: 2004 ident: 2038_CR5 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2004.30444.x – volume: 203 start-page: 3148 year: 2019 ident: 2038_CR64 publication-title: J Immunol doi: 10.4049/jimmunol.1900124 – volume: 31 start-page: 548 year: 2018 ident: 2038_CR45 publication-title: Viral Immunol doi: 10.1089/vim.2018.0035 – volume: 523 start-page: 612 year: 2015 ident: 2038_CR49 publication-title: Nature doi: 10.1038/nature14468 – volume: 12 start-page: 4474 year: 2021 ident: 2038_CR51 publication-title: Nat Commun doi: 10.1038/s41467-021-24734-0 – volume: 52 start-page: 1533 year: 2014 ident: 2038_CR27 publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2013-0926 – volume: 44 start-page: 947 year: 2014 ident: 2038_CR53 publication-title: Hepatol Res doi: 10.1111/hepr.12210 – volume: 97 start-page: 1184 year: 2000 ident: 2038_CR52 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.97.3.1184 – volume: 54 start-page: 730 year: 2019 ident: 2038_CR12 publication-title: J Gastroenterol doi: 10.1007/s00535-019-01565-x – volume: 68 start-page: 335 year: 2018 ident: 2038_CR3 publication-title: J Hepatol doi: 10.1016/j.jhep.2017.09.021 – volume: 2013 year: 2013 ident: 2038_CR58 publication-title: Clin Dev Immunol doi: 10.1155/2013/607073 – volume: 57 start-page: 807 year: 2018 ident: 2038_CR7 publication-title: Intern Med doi: 10.2169/internalmedicine.8887-17 – volume: 57 start-page: 125 year: 2012 ident: 2038_CR21 publication-title: J Hepatol doi: 10.1016/j.jhep.2012.02.029 – ident: 2038_CR29 doi: 10.1001/jamanetworkopen.2019.12565 – volume: 51 start-page: 1998 year: 2010 ident: 2038_CR62 publication-title: Hepatology doi: 10.1002/hep.23599 – volume: 52 start-page: 497 year: 2022 ident: 2038_CR14 publication-title: Hepatol Res doi: 10.1111/hepr.13764 – volume: 58 start-page: 79 year: 2023 ident: 2038_CR15 publication-title: J Gastroenterol doi: 10.1007/s00535-022-01932-1 – volume: 110 start-page: 1604 year: 2021 ident: 2038_CR20 publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.2423 – volume: 17 start-page: 81 year: 2020 ident: 2038_CR9 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0210-2 – volume: 10 start-page: 244 year: 2019 ident: 2038_CR34 publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00244 – volume: 10 start-page: 1255 year: 2019 ident: 2038_CR42 publication-title: Front Immunol doi: 10.3389/fimmu.2019.01255 – volume: 25 start-page: 233 year: 2016 ident: 2038_CR16 publication-title: Lupus doi: 10.1177/0961203315604910 – volume: 51 start-page: 586 year: 2016 ident: 2038_CR2 publication-title: J Gastroenterol doi: 10.1007/s00535-015-1129-1 – volume: 75 start-page: 1 year: 2020 ident: 2038_CR65 publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2020.02.001 – volume: 51 start-page: 850 year: 2021 ident: 2038_CR32 publication-title: Hepatol Res doi: 10.1111/hepr.13683 – volume: 154 start-page: 94 year: 2015 ident: 2038_CR6 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2015.07.020 – volume: 56 start-page: 951 year: 2021 ident: 2038_CR50 publication-title: J Gastroenterol doi: 10.1007/s00535-021-01796-x – volume: 327 start-page: 13 year: 2018 ident: 2038_CR60 publication-title: Cell Immunol doi: 10.1016/j.cellimm.2017.12.008 – volume: 115 start-page: 1289 year: 2020 ident: 2038_CR11 publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000000676 – volume: 10 start-page: 330 year: 2013 ident: 2038_CR1 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.41 – volume: 196 start-page: 97 year: 2016 ident: 2038_CR56 publication-title: J Immunol doi: 10.4049/jimmunol.1501175 – volume: 11 year: 2020 ident: 2038_CR39 publication-title: Front Immunol doi: 10.3389/fimmu.2020.575572 – ident: 2038_CR23 doi: 10.1097/MCG.0000000000001817 – volume: 45 start-page: 588 year: 2007 ident: 2038_CR46 publication-title: Hepatology doi: 10.1002/hep.21541 – volume: 116 start-page: 1413 year: 1999 ident: 2038_CR28 publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 10 start-page: 82 year: 2019 ident: 2038_CR57 publication-title: Front Immunol doi: 10.3389/fimmu.2019.00082 – volume: 52 start-page: 93 year: 2017 ident: 2038_CR48 publication-title: Scand J Gastroenterol doi: 10.1080/00365521.2016.1233576 – volume: 72 start-page: 45 year: 2020 ident: 2038_CR44 publication-title: J Hepatol doi: 10.1016/j.jhep.2019.08.024 – volume: 64 start-page: 113 issue: 5 year: 2018 ident: 2038_CR36 publication-title: Cell Mol Biol doi: 10.14715/cmb/2018.64.5.19 – volume: 65 start-page: 65 year: 2017 ident: 2038_CR13 publication-title: Hepatology doi: 10.1002/hep.28776 – volume: 75 year: 2022 ident: 2038_CR18 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103768 – volume: 74 start-page: 5 year: 2015 ident: 2038_CR37 publication-title: Cytokine doi: 10.1016/j.cyto.2014.09.011 – volume: 63 start-page: 971 year: 2015 ident: 2038_CR25 publication-title: J Hepatol doi: 10.1016/j.jhep.2015.06.030 – volume: 45 start-page: 143 year: 2013 ident: 2038_CR33 publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-013-8383-x – volume: 13 start-page: 88 year: 2016 ident: 2038_CR59 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2015.200 – volume: 135 start-page: 1333 year: 2008 ident: 2038_CR47 publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.06.042 – volume: 10 start-page: 2172 year: 2019 ident: 2038_CR54 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02172 – volume: 37 start-page: 923 year: 2007 ident: 2038_CR4 publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2007.00150.x – volume: 33 start-page: 53 year: 2015 ident: 2038_CR31 publication-title: Dig Dis doi: 10.1159/000440747 – volume: 113 start-page: 8490 year: 2016 ident: 2038_CR40 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1608873113 – volume: 40 start-page: 331 year: 2020 ident: 2038_CR55 publication-title: Semin Liver Dis doi: 10.1055/s-0040-1713006 – volume: 99 start-page: 273 year: 2021 ident: 2038_CR38 publication-title: Cytometry A doi: 10.1002/cyto.a.24272 – ident: 2038_CR26 doi: 10.1007/s00535-016-1267-0 – volume: 69 start-page: 301 year: 2018 ident: 2038_CR43 publication-title: Annu Rev Med doi: 10.1146/annurev-med-012017-043208 – volume: 15 year: 2020 ident: 2038_CR24 publication-title: PLoS ONE doi: 10.1371/journal.pone.0239481 – volume: 10 year: 2015 ident: 2038_CR22 publication-title: PLoS ONE doi: 10.1371/journal.pone.0143380 |
SSID | ssj0013058 |
Score | 2.4212396 |
Snippet | Background
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody... Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA)... Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody... BackgroundNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1237 |
SubjectTerms | Abdominal Surgery Antinuclear antibodies Apoptosis Autoantibodies Autoimmune diseases Autoimmunity B cells Biliary Tract Biopsy CD8 antigen Cell death Chronic active hepatitis Colorectal Surgery Cytotoxicity Fatty liver Flow cytometry Gastroenterology Helper cells Hepatitis Hepatitis, Autoimmune - complications Hepatology Humans Hyaluronic acid Immunity Immunoregulation Liver Liver diseases Lymphocytes Lymphocytes B Lymphocytes T Medical research Medicine Medicine & Public Health Medicine, Experimental Natural killer cells Non-alcoholic Fatty Liver Disease - complications Original Article―Liver Pancreas PD-1 protein Risk Factors Surgical Oncology T cells |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpY-kcZoWFQo9pCKWLVv2qYTSEArJqYG9CUmWk4XF3iTewP6Q_t_MaOXdbqC5-CJZ1u48NTP6BuCrV8Ki4fM8NZaiVUZw49qai8rbwmZNUQW4pvOL8uxS_p4Ukxhwu4tllaNODIq66R3FyI_xYCAKPM6k2Y_5DaeuUZRdjS00nsMLgi6jki41UZssQhr6c-IJRnKBrne8NBOuzgVgE44Wi1MuruLLLcP0WD3_Y58eJUyDHTp9A6-jA8lOVhR_C8989w5enscU-Xv4e0EB1ntDZelsRAxnQ88oOU3lT4yqyVnss8P6lnXkjIdGuVPHiOhDf-2p0HqY4vg9BfwIxOGKmcXQT-k-iWebCWQGG9Z3jCCTA0bBjM2WyCO9W-LH5gG_s9uFy9Nff36e8dh7gTs8gQy8bA26MsplrRGZqVQujGhI3kUjGlNJm9vc10WL3oB0qUuVdahyCy8kPtqmyvdgB7fv94EZWxMqoTC4ksx9WbdtLZEP8grXtYVMQIx_vHYRmJz6Y8z0GlI5EEsjsXQgll4mcLR-Z76C5Xhy9jeipyaZxZWdiVcPcH-EfqVPlMpRN2WqTuBwaybKmtseHjlCR1m_0xvOTODLepjepPq1zvcLmlPKqi7Ru0rgw4qT1vvOlUK_rS4S-D6y1mbx__-og6f38hFeZcTdofLmEHaG24X_hP7TYD8HIXkAcckXtA priority: 102 providerName: ProQuest |
Title | Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern |
URI | https://link.springer.com/article/10.1007/s00535-023-02038-y https://www.ncbi.nlm.nih.gov/pubmed/37707595 https://www.proquest.com/docview/2891582502 https://www.proquest.com/docview/2864896512 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZeRrtPd23QYLCHTWD5S_ZjEpKVjYYxFsiejCTLXSDYZXUK-UP6_-5OsZ2mbIO9xA-SL0ruTnfS3f0O4J2VQqPhs9xXmm6rlODKlBkXqdWxDoo4dXBNl7PkYh59XsSLtijspst270KSbqfui90cFAlHG8MpepbyzQEcxXR2RymeB8Nd7MB3XTnx3BJxgQ53WyrzZxp75ujhpnzPKj0IkzrrMz2Gp63byIZbPp_AI1s9g8eXbWD8OdzN6Fr1VlEyOutwwllTMwpJU9IToxxy1nbXYXXJKnLBXXvcpWHE6qb-aSm9ulni-C1d8xF0wxVT66ZeUhWJZbsJZPwKVleMgJIdMsGKrTYoGbXZ4JddO9TO6gXMp5Pv4wvedlzgBs8dDU9KhQ6MNEGpRKBSGQolCtJyUYhCpZEOdWizuEQfIDK-8aU2uNHGVkT4URZp-BIOcfn2NTClM8IiFAopRaFNsrLMIuR-mCJdHUceiO6Pz00LR05dMVZ5D6TsmJUjs3LHrHzjwYf-nestGMc_Z78nfuakqUjZqLbgANdHmFf5UMoQd6RAZh6c7c1EDTP7w51E5K2G3-R4UBUxHq_9wIO3_TC9SVlrla3XNCeJ0ixBn8qDV1tJ6tcdSoneWhZ78LETrR3xv_-o0_-b_gaeBCTtLv_mDA6bX2t7jl5UowdwIBdyAEfD6Wg0o-enH18m-BxNZl-_4eg4GQ-cYv0GIZkbfw |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4gAWceK8DggVaLWl3RVCrdSbcRyHrrRKtjRblB_C3-A3MuNNdtlK9NZLLnYc7854Hp6ZbwBe2kTkqPgs93VOt1VacG3KjIvU5lEeFFHq4JpG43h4JL8cR8cb8KevhaG0yl4mOkFd1IbuyN-hYyAidGf84MPslFPXKIqu9i00Fmyxb9tf6LKdvd_7jPR9FQS7O4efhrzrKsAN2tYNj0uNSjoxQalFoNMkFFoUxMmiEIVOZR7moc2iEvWcNL7xk9ygMImskPgoizTEda_BpgzRlRnA5sed8ddvq7iF7zqCos8kuUBjvyvTccV6DkqFo47kFP1LebumCi8qhH804oUQrdN8u7fhVmeysu0Fj92BDVvdheujLih_D36P6Ur3XFMiPOsxyllTMwqHU8IVo_x11nX2YXXJKjL_XWveiWHEZk19Yim1u5ng-DldMRJsxA-m5009oQoWy1YTSPEWrK4YgTQ7VIQpm7bIlbVp8WMzhxha3YejK6HLAxjg9u0jYDrPCAdRaFxJhjbOyjKTyHlhiuvmkfRA9H-8Mh0UOnXkmKoliLMjlkJiKUcs1XrwZvnObAEEcuns10RPRVICVza6K3bA_RHeltpOkhClYZBkHmytzcTTbdaHe45QnXQ5U6uz4MGL5TC9SRlzla3nNCeWaRajPefBwwUnLfcdJglailnkwduetVaL__9HPb58L8_hxvBwdKAO9sb7T-BmQJzu8n62YND8nNunaL01-bPuyDD4ftWn9C-xPlVH |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlVcEP8EChgJxAGsxvlzckCooqxaSlccqLQ3YzsOrLRKFpotyoPwMjwdM95kl61Eb73kYsfx7nzjGXvG3wC8cFIYNHyOh9rQaZUWXNuq4CJ3JjVRmeaerulknB2eJh8n6WQL_gx3YSitclgT_UJdNpbOyPdwYyBS3M6E0V7Vp0V8Phi9m__gVEGKIq1DOY0lRI5d9wu3b2dvjw5Q1i-jaPThy_tD3lcY4Bb97JZnlUaDLW1UaRHpXMZCi5JQLUpR6jwxsYldkVZo8xIb2lAaiwtL6kSCj6rMYxz3GlyXcSpIx-REriMYoa8NirunhAt0-_sLO_7anidV4WgtOcUBc95tGMWLpuEf23ghWOtt4OgW3OydV7a_RNtt2HL1Hdg56cPzd-H3mA53zzWlxLOBrZy1DaPAOKVeMcpkZ32NH9ZUrKaNgC_SO7WMANc23x0lebdTbD-nw0YikPjG9KJtpnSXxbF1BzLBJWtqRnTNnh9hxmYd4rOxHX5s7rlD63tweiVSuQ_bOH33EJg2BTEiCo0jJbHLiqoqEsRgnOO4Jk0CEMMfr2xPik61OWZqRefshaVQWMoLS3UBvF69M19Sglza-xXJU9F6gSNb3V97wPkR85bal4SeMJJFALsbPVHP7WbzgAjVrzNnaq0VATxfNdOblDtXu2ZBfbIkLzL07AJ4sETSat6xlOgzFmkAbwZorQf__496dPlcnsEO6qb6dDQ-fgw3IgK6TwDahe3258I9QTeuNU-9vjD4etUK-hfhbVgX |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+approach+to+indicate+risk+factors+of+nonalcoholic+steatohepatitis+overlapping+autoimmune+hepatitis+based+on+peripheral+lymphocyte+pattern&rft.jtitle=Journal+of+gastroenterology&rft.au=Kado%2C+Akira&rft.au=Tsutsumi%2C+Takeya&rft.au=Yotsuyanagi%2C+Hiroshi&rft.au=Ikeuchi%2C+Kazuhiko&rft.date=2023-12-01&rft.issn=0944-1174&rft.eissn=1435-5922&rft.volume=58&rft.issue=12&rft.spage=1237&rft.epage=1251&rft_id=info:doi/10.1007%2Fs00535-023-02038-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00535_023_02038_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon |